Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.
about
Homeopathy for treatment of irritable bowel syndromeHomeopathy for treatment of irritable bowel syndromeProbiotic agents for the treatment of diarrhoea-predominant irritable bowel syndromeWhat is the relationship between the minimally important difference and health state utility values? The case of the SF-6DRandomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind studyResponders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-CA systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndromeHow does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.Impact of functional gastrointestinal disorders on survival in the community.Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.The impact of irritable bowel syndrome on health-related quality of life: a Singapore perspective.Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case-control study.Cost-effectiveness of acupuncture for irritable bowel syndrome: findings from an economic evaluation conducted alongside a pragmatic randomised controlled trial in primary care.A protocol for a trial of homeopathic treatment for irritable bowel syndrome.Anxiety, depression and quality of life in patients with irritable bowel syndromeGP perspectives of irritable bowel syndrome--an accepted illness, but management deviates from guidelines: a qualitative studyTranslation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J)Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceChange in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort StudyComparison of medical costs generated by IBS patients in primary and secondary care in the NetherlandsComprehensive psychological intervention to improve outcome in functional gastrointestinal disorder: a cohort study.Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom.Current and emerging therapies for the management of functional gastrointestinal disorders.Systematic review: the efficacy of treatments for irritable bowel syndrome--a European perspective.The impact of HIV-associated lipodystrophy on healthcare utilization and costs.Relationship of abuse history to functional gastrointestinal disorders and symptoms: some possible mediating mechanisms.Mental Strain and Chronic Stress among University Students with Symptoms of Irritable Bowel Syndrome.Prevalence, impact and attitudes toward lower gastrointestinal dysmotility and sensory symptoms, and their treatment in Canada: A descriptive study.Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort.Economic burden of irritable bowel syndrome in China.Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic surveyHealth Related Quality of Life in Iranian Patients With Irritable Bowel Syndrome: Reliability and Validity of the Persian Version of the IBS-QOL.Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions.Quality of life in irritable bowel syndrome: measurement techniques and relevance of current knowledge.How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?HRV biofeedback for pediatric irritable bowel syndrome and functional abdominal pain: a clinical replication series.Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service.A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.Establishment of Health Utility Indices for Post-Infectious Functional Gastrointestinal Disorders in Active Duty US Military.Differences between painless and painful constipation among community women.
P2860
Q24201616-292B3BB4-F9CD-44A1-BB49-D15605EDCCCAQ24202472-0EA4906B-9462-400F-9799-11B9592A50C0Q24244086-108EDDE8-B95C-4B7E-B7D5-F47AB6556115Q24796975-0F053342-87B0-4889-943C-859B68C4AE85Q28239840-0D9B66B0-F7BC-4DBF-AA5F-8CEF12590A1FQ30724990-D24158D5-1798-42E1-952C-1F589AC7D2D6Q33409756-8DD75D03-1A52-4D6D-A5DE-24D46E9915BDQ33541333-B51A90A4-E508-4C24-AF4E-DE24FF5EA230Q33919405-54FC296C-E655-485F-A482-DCFAB6C0B438Q34309302-E87AB60E-3963-49FB-9EA9-571A70D23F53Q34371413-332F86D1-EF13-40A4-8488-05A62BD72804Q34403939-BAD80DC9-B42D-4EE3-A7FF-8611D9B9A94DQ34457016-9D0FD225-98B6-4BA4-9B8D-9A047E3E2ECCQ34468338-46937223-D6E9-4BE2-8338-ACB1712C1848Q34725834-AD4E5CF3-6C01-4F5A-BAA2-F65EC787F3A1Q34785932-C7B2A170-ED50-40AF-A7A3-2B2B2A7F31B1Q35699652-6FE60139-3742-4122-9DA2-B969DD0AE505Q35768888-83BCAD52-37D7-4CC0-A496-B03F69A0DEF1Q35797307-E9249EB0-43E9-4361-B5A5-4D143B2E48C1Q35854169-9B7E227E-B5D2-4E0D-80B5-01959D9BC66EQ35905031-8B8A7971-2B52-45CA-A56B-758FCE218C7FQ36401806-866DA1FA-F643-4151-B6FE-27EBEBB38D0BQ36443725-B34FED0C-A041-4C86-9875-70DEAA5960AFQ36536707-A099D53D-E096-4F89-A19C-153C17170535Q36782539-FE02A699-A5A9-4E09-9E52-B860B8388669Q36862809-B2CEE02F-DF71-4246-BBE5-A2C75CE7127FQ36969663-DA094AED-7E42-4484-83A0-444BBAA62DA3Q37130709-81683ED5-D607-4377-B034-2FD011EB1971Q37340278-3FFD3AE5-3D89-4AA0-870B-7FBFED87DCBAQ37522698-0A991F4D-58B0-4095-849F-48C23AF4ED80Q37542854-98007B3B-86CC-4060-8741-46F74AF90140Q37569190-5B8174C4-ED48-41C3-9E85-63E2C0E5DA58Q37595198-AD0D9FFA-6C1F-42D8-8CAC-20C47CA3BEBEQ37609329-2C1E9FDC-8EA8-4B47-9E80-CE2FEBF7475BQ38122001-1631C939-1FB6-4362-AA94-EA5A6CC07832Q38389940-2023F668-9137-4D6B-9563-2F1DBCC5F7DDQ38608981-9A197AAD-753A-4844-886A-AE58405B4324Q39302253-4E18892F-E430-4134-B60B-0E39A50CBE29Q39364573-F4593B95-53C2-4B03-BCC3-325E525059F3Q43452774-67DE5088-A84F-4C38-B29F-3ADB5AAA0381
P2860
Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Health-related quality of life ...... in a UK primary care setting.
@ast
Health-related quality of life ...... in a UK primary care setting.
@en
Health-related quality of life ...... in a UK primary care setting.
@nl
type
label
Health-related quality of life ...... in a UK primary care setting.
@ast
Health-related quality of life ...... in a UK primary care setting.
@en
Health-related quality of life ...... in a UK primary care setting.
@nl
prefLabel
Health-related quality of life ...... in a UK primary care setting.
@ast
Health-related quality of life ...... in a UK primary care setting.
@en
Health-related quality of life ...... in a UK primary care setting.
@nl
P2093
P1433
P1476
Health-related quality of life ...... in a UK primary care setting.
@en
P2093
Anne Morgan
Caroline O'Keefe
Eva Kaltenthaler
John E Brazier
Maria Platts
Nigel Mathers
Ron L Akehurst
Stephen J Walters
P304
P356
10.2165/00019053-200220070-00003
P577
2002-01-01T00:00:00Z
P5875
P6179
1020593308